{"transactions":[{"id":3691714,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":160962,"kind":"person","name":"Tepper Mark","position":1,"cik":"0001291087","reported_name":"Tepper Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option(right to buy)","published_at":"2019-01-18T16:57:38.000Z","date":"2019-01-18","kind":"grant","acquired":true,"shares":195000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on January 18, 2020, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 18, 2020."}],"balance_after":195000,"derivative":{"exercise_price":7.53,"expiration_date":"2029-01-18","underlying":"Common Stock","underlying_shares":195000},"source":{"system":"sec-edgar","filing":"0001209191-19-004574","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1291087/000120919119004574/doc4.xml","form_type":"4"}},{"id":3760739,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":160962,"kind":"person","name":"Tepper Mark","position":1,"cik":"0001291087","reported_name":"Tepper Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Option to purchase common stock","published_at":"2018-11-16T16:09:41.000Z","date":"2018-11-14","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":261600,"derivative":{"exercise_price":1,"exercise_date":"2015-04-11","expiration_date":"2024-04-11","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-18-058931","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1291087/000120919118058931/doc4.xml","form_type":"4"}},{"id":3760738,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":160962,"kind":"person","name":"Tepper Mark","position":1,"cik":"0001291087","reported_name":"Tepper Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2018-11-16T16:09:41.000Z","date":"2018-11-14","kind":"exercise","acquired":true,"shares":10000,"price":1,"value":10000.0,"ownership":{"direct":true},"balance_after":2110400,"source":{"system":"sec-edgar","filing":"0001209191-18-058931","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1291087/000120919118058931/doc4.xml","form_type":"4"}},{"id":4105299,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":160962,"kind":"person","name":"Tepper Mark","position":1,"cik":"0001291087","reported_name":"Tepper Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option(right to buy)","published_at":"2018-01-05T17:28:50.000Z","date":"2018-01-04","kind":"grant","acquired":true,"shares":175000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on January 4, 2019, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on February 4, 2019."}],"balance_after":175000,"derivative":{"exercise_price":8.35,"expiration_date":"2028-01-04","underlying":"Common Stock","underlying_shares":175000},"source":{"system":"sec-edgar","filing":"0001209191-18-002514","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1291087/000120919118002514/doc4.xml","form_type":"4"}},{"id":4403398,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":160962,"kind":"person","name":"Tepper Mark","position":1,"cik":"0001291087","reported_name":"Tepper Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option(right to buy)","published_at":"2017-03-03T16:20:05.000Z","date":"2017-03-01","kind":"grant","acquired":true,"shares":115000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on March 1, 2018, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on April 1, 2018."}],"balance_after":115000,"derivative":{"exercise_price":9.05,"expiration_date":"2027-03-01","underlying":"Common Stock","underlying_shares":115000},"source":{"system":"sec-edgar","filing":"0001209191-17-017496","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1291087/000120919117017496/doc4.xml","form_type":"4"}},{"id":4582490,"issuer":{"id":6261,"kind":"organization","name":"Corbus Pharmaceuticals Holdings, Inc.","symbol":"CRBP"},"owners":[{"id":160962,"kind":"person","name":"Tepper Mark","position":1,"cik":"0001291087","reported_name":"Tepper Mark","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option(right to buy)","published_at":"2016-10-07T16:52:27.000Z","date":"2016-10-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option award was made in accordance with the terms of the issuer's 2014 Equity Compensation Plan. 25% of the option vests on October 6, 2017, with the remaining 75% of the option vesting in equal monthly installments over a period of 36 months commencing on November 6, 2017."}],"balance_after":150000,"derivative":{"exercise_price":8.71,"expiration_date":"2026-10-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-16-145416","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1291087/000120919116145416/doc4.xml","form_type":"4"}}]}